These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12574891)

  • 41. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness of implantable cardioverter-defibrillators.
    Sanders GD; Hlatky MA; Owens DK
    N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The problem of indeterminate microvolt T-wave alternans results in patients with left ventricular dysfunction referred for implantable cardioverter-defibrillator implantation in the primary prevention of sudden cardiac death.
    Daniłowicz Szymanowicz L; Szwoch M; Kempa M; Raczak G
    Kardiol Pol; 2012; 70(8):795-802. PubMed ID: 22933211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening and therapy for patients with nonsustained ventricular tachycardia.
    Prystowsky EN
    Am J Cardiol; 2000 Nov; 86(9A):34K-39K. PubMed ID: 11084098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
    Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
    Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prediction of sudden and non-sudden cardiac death in post-infarction patients with reduced left ventricular ejection fraction by periodic repolarization dynamics: MADIT-II substudy.
    Rizas KD; McNitt S; Hamm W; Massberg S; Kääb S; Zareba W; Couderc JP; Bauer A
    Eur Heart J; 2017 Jul; 38(27):2110-2118. PubMed ID: 28431133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estimation of the requirement for implantable cardioverter defibrillators for the primary prevention of sudden cardiac death post-myocardial infarction based on UK national guidelines (2006).
    Scott PA; Gorman S; Andrews NP; Roberts PR; Kalra PR
    Europace; 2008 Apr; 10(4):453-7. PubMed ID: 18319266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MADIT-II: clinical implications.
    Moss AJ; Daubert J; Zareba W
    Card Electrophysiol Rev; 2002 Dec; 6(4):463-5. PubMed ID: 12438829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia Trial.
    Singh SN; Karasik P; Hafley GE; Pieper KS; Lee KL; Wyse DG; Buxton AE;
    Am J Cardiol; 2001 Mar; 87(6):716-20. PubMed ID: 11249889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extreme electrical storm in a patient with an implantable cardioverter defibrillator.
    Sela R; Gellerman M; Kalfon E; Atar S
    Isr Med Assoc J; 2014 Aug; 16(8):513-5. PubMed ID: 25269346
    [No Abstract]   [Full Text] [Related]  

  • 51. Primary prevention of sudden cardiac death with implantable cardioverter defibrillators: lessons learned from MADIT and MUSTT.
    Gold MR; Nisam S;
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1981-5. PubMed ID: 11139972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noninvasive risk stratification in postinfarction patients with severe left ventricular dysfunction and methodology of the MADIT II noninvasive electrocardiology substudy.
    Zareba W; Moss AJ
    J Electrocardiol; 2003; 36 Suppl():101-8. PubMed ID: 14716600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk stratification using heart rate turbulence and ventricular arrhythmia in MADIT II: usefulness and limitations of a 10-minute holter recording.
    Berkowitsch A; Zareba W; Neumann T; Erdogan A; Nitt SM; Moss AJ; Pitschner HF
    Ann Noninvasive Electrocardiol; 2004 Jul; 9(3):270-9. PubMed ID: 15245344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: effect of endurance exercise training.
    Billman GE
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1171-93. PubMed ID: 19684184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonsustained ventricular tachycardia and other high-risk predictors following myocardial infarction: implications for prophylactic automatic implantable cardioverter-defibrillator use.
    Wilber DJ; Kopp D; Olshansky B; Kall JG; Kinder C
    Prog Cardiovasc Dis; 1993; 36(3):179-94. PubMed ID: 8234772
    [No Abstract]   [Full Text] [Related]  

  • 56. Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction.
    Bailey JJ; Berson AS; Handelsman H; Hodges M
    J Am Coll Cardiol; 2001 Dec; 38(7):1902-11. PubMed ID: 11738292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cardiac remodeling after myocardial infarction : Clinical practice update].
    Ertl G; Brenner S; Angermann CE
    Herz; 2017 Feb; 42(1):107-120. PubMed ID: 28105480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Noninvasive risk stratification after myocardial infarction: rationale, current evidence and the need for definitive trials.
    Exner D
    Can J Cardiol; 2009 Jun; 25 Suppl A(Suppl A):21A-27A. PubMed ID: 19521570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Occurrence of abnormal late ventricular potentials in myocardial ischemia and the determination of risk of sudden cardiac death in patients after myocardial infarct].
    Filipová S; Mikus P; Cagán S
    Bratisl Lek Listy; 1996 Aug; 97(8):463-72. PubMed ID: 8963697
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Arrhythmia and left ventricle remodeling in acute myocardial infarct: recommendations for drug therapy].
    Kusljugić Z; Divković K; Braković F; Smajić E; Buksa M; Praso M; Boskailo H
    Med Arh; 2004; 58(2 Suppl 1):5-7. PubMed ID: 15202297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.